Results 231 to 240 of about 158,005 (297)
This review critically evaluates clotrimazole as a potential antifungal for finfish aquaculture, highlighting strong mechanistic and in vitro efficacy against aquatic mycoses alongside major gaps in in vivo evidence, toxicokinetics, residue safety, and environmental risk, outlining priorities for responsible therapeutic development and regulatory ...
Arya Sen +2 more
wiley +1 more source
Lipid-Lowering Therapy in Post-Acute Coronary Syndrome Patients: An Observational Study. [PDF]
Alwagdani MS +7 more
europepmc +1 more source
Cytokine Pathways Driving Diverse Tissue Pathologies in Rheumatoid Arthritis
Rheumatoid arthritis (RA) is a complex systemic disorder characterized primarily by articular inflammation and destruction with associated functional loss and reduced quality of life. RA is also associated with extra‐articular disease, such as that of the lung, with potentially devastating clinical consequences. The critical importance of comorbidities,
Aurelie Najm +2 more
wiley +1 more source
Low-intensity versus moderate- to high-intensity lipid-lowering therapy after myocardial infarction in patients aged 80 years and older: A retrospective cohort study. [PDF]
Jiang S +10 more
europepmc +1 more source
Objective Rheumatoid sarcopenia, characterized by the progressive loss of skeletal muscle mass and function, is a frequent comorbidity in rheumatoid arthritis (RA), linked to prolonged, severe systemic inflammation. Purinergic signaling (adenosine, AMP, and ATP) plays a crucial role in inflammation, myogenesis, and muscle hypertrophy.
Miguel Marco‐Bonilla +13 more
wiley +1 more source
Objective Evaluate performance of the Predicting Risk of Cardiovascular Disease Events (PREVENT) calculator in rheumatoid arthritis (RA). Methods Patients with RA were matched up to 10 controls on age, sex, and enrollment year using National Veterans Health Administration, Medicare, and National Death Index data (2006–2020).
Tate M. Johnson +13 more
wiley +1 more source
Cardiovascular Risk Assessment and Lipid-Lowering Therapy Recommendations in Primary Prevention. [PDF]
Komnianou A +5 more
europepmc +1 more source
Impact of dyslipidemia and lipid-lowering therapy with statins in patients with neuroendocrine tumors. [PDF]
Faggiano A +22 more
europepmc +1 more source
Cardiovascular disease and compliance with lipid-lowering therapy among young individuals with familial hypercholesterolemia in Norway - A register study. [PDF]
Langslet G +5 more
europepmc +1 more source

